Kelyniam Global records sales growth despite revenue dip in 2023
Kelyniam Global (OTC:KLYG), a renowned custom cranial implant manufacturer, has released its financial results for the year ending December 31, 2023. CEO Ross Bjella announced a record-setting fourth quarter in unit sales, contributing to a modest increase in unit volume…